fosinopril has been researched along with Hypertension in 163 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (1.84) | 18.7374 |
1990's | 92 (56.44) | 18.2507 |
2000's | 53 (32.52) | 29.6817 |
2010's | 14 (8.59) | 24.3611 |
2020's | 1 (0.61) | 2.80 |
Authors | Studies |
---|---|
Abboa-Offei, BE; Asaad, MM; Bednarz, MS; Chao, S; Cheung, HS; Cimarusti, MP; Dejneka, T; Fox, M; Mathers, PD; Misra, RN; Robl, JA; Ryono, DE; Schaeffer, TR; Seymour, AA; Simpkins, LM; Slusarchyk, WA; Smith, PL; Stevenson, J; Stratton, L; Sun, CQ; Trippodo, NC | 1 |
Facchetti, R; Grassi, G; Mancia, G; Quarti-Trevano, F | 1 |
Gao, R; Li, G; Li, X; Wen, Y; Yue, C | 1 |
Fang, C; Huang, ZB; Lin, MH; Wu, W; Yuan, GY; Zhou, SX | 1 |
Bezruchko, BP; Gridnev, VI; Karavaev, AS; Kiselev, AR; Ponomarenko, VI; Posnenkova, OM; Prokhorov, MD | 1 |
Drozd, VIu; Haĭdychuk, VS; Khukhlina, OS; Kosar, LIu; Mandryk, OIe | 1 |
Feng, Y; Huang, R; Li, X; Melgiri, ND; Qin, X; Sun, Y; Wang, Y | 1 |
Dai, B; Lv, J; Mei, C; Wang, Y; Xue, C; Yang, B; Yu, S; Zhao, G; Zhou, C | 1 |
Ferguson, JM; Komesaroff, PA; Minas, J; Siapantas, S; Sudhir, K | 1 |
Argiolas, G; Bulla, E; Bulla, P; Degortes, S; Fadda, S; Filigheddu, F; Frau, F; Glorioso, N; Pitzoi, S; Troffa, C; Zaninello, R | 1 |
Ao, X; Tang, R; Tang, TF; Zhou, QL; Zhu, LL | 1 |
Qin, YW; Qiu, JL; Zhang, JL; Zhao, XX; Zheng, X; Zou, DJ | 1 |
Buniatian, ND; Lednev, OA; Sergeev, SV; Zaslavskaia, RM | 1 |
Bilo, G; Crepaldi, G; Giuliano, A; Mancia, G; Parati, G; Revera, M; Veglia, F; Zanchetti, A | 1 |
Buyukhatipoglu, H; Tiryaki, O; Usalan, C | 1 |
Liang, X; Meng, Y; Qi, G; Wu, C; Zhang, Z | 1 |
Cheng, X; Lin, S; Wu, R; Zhou, Q | 1 |
Liu, Z; Pouranan, V; Tang, R; Xiao, Z; Zhou, Q | 1 |
Ao, X; Peng, WS; Tang, R; Tang, TF; Veeraragoo, P; Zhou, QL | 1 |
Cridlig, J; Kessler, M; Lehert, P; Rossignol, P; Zannad, F | 1 |
Erem, C; Kavgaci, H; Onder Ersoz, H; Ozdemir, F; Sahin, A | 1 |
Bicket, DP | 1 |
Maniu, CV; Meyer, DM; Redfield, MM | 1 |
Liang, X; Sun, M; Xie, X; Yang, T; Yu, G; Zhao, S | 1 |
Corradi, L; Derosa, G; Fogari, R; Lazzari, P; Marasi, G; Mugellini, A; Pasotti, C; Poletti, L; Preti, P; Rinaldi, A; Voglini, C; Zoppi, A | 1 |
Chiandussi, L; Milan, A; Morello, F; Mulatero, P; Paglieri, C; Rabbia, F; Veglio, F | 1 |
Gedgafova, SIu; Martynov, AI; Ostroumova, OD; Pustovitova, TS; Sharkova, NE; Sinitsyn, VE; Ternovoĭ, SK | 1 |
Karpov, YA | 1 |
Angulo, E; Barquero, A; Grois, J; Pérez Miranda, M; Robles, NR | 1 |
Liang, XQ; Yu, GL; Zheng, JQ | 1 |
He, BX; Liang, XQ; Yu, GL | 1 |
Lal, SM; Trivedi, H | 1 |
Dai, G; Huang, K | 1 |
Gilbert, RE; Krum, H; Skiba, M | 1 |
Connolly, WE; Mainville, N | 1 |
Beaulieu, M; Cléroux, J; Lacourcière, Y; Nadeau, A | 1 |
Larouche, I; Pu, Q; Schiffrin, EL | 1 |
George, A; Shakib, S | 1 |
Burrell, LM; Cooper, ME; Jaworski, K; Kubota, E; Mifsud, SA; Wilkinson-Berka, JL | 1 |
Pfützner, W; Przybilla, B; Ruëff, F | 1 |
Berezny, K; Califf, RM; Cottrill, CM; Deitchman, D; Hazan, L; Hogg, R; Jenkins, RD; Kanani, P; Kilaru, R; Kozlova, L; Li, JS; Mattoo, TK; Portman, R; Weisman, I; Zharkova, L | 1 |
Jian-Li, Q; Jian-Liang, Z; Jiang, C; Rong-Liang, X; Xing, Z; Yong-Wen, Q | 1 |
Angulo, E; Barquero, A; Grois, J; Robles, NR | 1 |
Baggio, G; Bond, MG; Crepaldi, G; Gallus, G; Magni, A; Mancia, G; Rubba, P; Sampieri, L; Sperti, G; Veglia, F; Ventura, A; Zanchetti, A | 1 |
Atilgan, D; Bilge, AK; Koylan, N; Meriç, M; Ozben, B; Ozcan, M; Tükek, T | 1 |
Logacheva, IV; Morozova, NI; Shustova, EN | 1 |
Gapon, LI; Pliusnin, AV; Popova, SN; Veber, EE; Vershinina, AM | 1 |
Fomin, VV; Moiseev, SV | 1 |
Cookson, T; Gates, R; Gifford, A; Ito, M; Le, TN; Marcus, D; Nguyen, CN | 1 |
Grünfeld, JP; Kessler, M; Lechat, P; Lehert, P; Leizorovicz, A; Thuilliez, C; Zannad, F | 1 |
Benjamin, DK; Berezny, KY; Califf, RM; Deitchman, D; Hazan, L; Hogg, R; Kay, JD; Kilaru, R; Li, JS; Menon, S; Portman, R | 1 |
Chen, L; Cheng, WL; Fan, SY; Ju, G; Ke, YN; Shi, ZX; Wang, Y | 1 |
Kazory, A; Weiner, ID | 1 |
García-Testal, A; González, A; Monzó, A; Rabanaque, G; Romeu, A | 1 |
Medvedev, IN; Simonenko, VB; Tolmachev, VV | 1 |
Basi, S; Fesler, P; Lewis, JB; Mimran, A | 1 |
Cloro, C; Maio, R; Marcantonio, AM; Mattioli, PL; Perticone, F; Pugliese, F | 1 |
Bettoni, G; Castellano, M; Cinelli, A; Muiesan, ML; Porteri, E; Rizzoni, D; Rosei, EA | 1 |
De Girolamo, V; Guerriero, C; Loguercio, C; Piscopo, P; Valese, C | 1 |
Chang, MS; Chen, CH; Chou, P; Hsu, TL; Lin, SJ; Siu, CO; Ting, CT; Wang, SP; Yin, FC | 1 |
Aurigemma, GP; Douglas, PS; Katz, SE; Litwin, SE; Lorell, BH; Weinberg, EO | 1 |
Kirpizidis, HG; Papazachariou, GS | 1 |
Scheen, AJ | 1 |
Ellis-Pegler, EM; Gamble, GD; Greaves, SC; Holdaway, IM; Sanders, GA; Sharpe, N | 1 |
Evans, BL; Pylypchuk, GB; Sharif, MN | 1 |
Andersson, PE; Haenni, A; Lithell, H; Reneland, R | 1 |
Bastani, B; Redington, J | 1 |
Franco, RJ; Martín, LC; Velasco-Cornejo, IF | 1 |
Benedict, CR; Douglas, PS; George, D; Kagaya, Y; Litwin, SE; Lorell, BH; Schoen, FJ; Schunkert, H; Weinberg, EO | 1 |
Cappelletti, C; Cecchi, L; Fortini, A; Laureano, R | 1 |
Duchin, KL; Gehr, TW; Grasela, DM; Sica, DA | 1 |
Chierichetti, F; Claroni, F; Fazari, G; Ferlin, G; Meneghetti, G; Pessina, AC; Semplicini, A; Serena, L; Simonella, C | 1 |
Lithell, H; Reneland, R | 2 |
Binder, SB | 1 |
Almeida, FA; Chaves, H; Kohlmann Júnior, O; Lima Júnior, E; Luna, RL; Mion Júnior, D; Nicolau, JC; Rocha, JC; Saragoça, M; Spritzer, N | 1 |
Arriaga, J; Camacho, P; Fernández, M; González, D; Madero, R; Villalpando, J | 1 |
Guthrie, R | 1 |
Batlle, DC; Keilani, T; Schlueter, W | 1 |
Grossman, E; Messerli, FH; Oren, S; Schmieder, RE; Soria, F | 1 |
Alpin, PG; Ford, NF; Fulmor, IE; Herron, JM; Nichola, PS | 1 |
Frohlich, ED; Grossman, E; Oren, S | 1 |
Beschi, M; Bettoni, G; Böhm, M; Castellano, M; Cinelli, A; Porteri, E; Rizzoni, D; Rosei, EA | 1 |
Hess, E; Sperschneider, H; Stein, G | 1 |
Aviram, M; Keidar, S; Leiba, A; Leiba, M; Oiknine, J; Shapira, C | 1 |
Battikha, JP; Guthrie, R; Plesher, MM; Reggi, DR; Saini, RK | 1 |
Carrageta, M; de Freitas, AF; Domingues, J; Gouveia, AC; Lima, MJ; Monteiro, A; Pizarro, M | 1 |
Aärynen, M; Forslund, T; Hansson, L; Höglund, C; Istad, H; Kjellström, T; Kristinsson, A; Lederballe-Pedersen, O; Segaard, E; Svensson, A; Wahrenberg, H; Wennersten, G | 1 |
Mancia, G; Omboni, S; Ravogli, A; Villani, A | 1 |
Davis, R; McTavish, D; Wagstaff, AJ | 1 |
Agrati, AM; Alli, C; Cassani, M; Granata, S; Lombardo, M; Zanni, D | 1 |
Barry, WH; Gwathmey, JK; Hajjar, RJ; Kagaya, Y; Lorell, BH | 1 |
Battikha, JP; Cushman, WC; Nwachuku, CE; Pool, JL; Saini, RK | 1 |
Anderssson, PE; Berglund, L; Haenni, A; Lind, L; Lithell, H; Reneland, R | 1 |
Almenar, L; Flores, A; Osa, A; Palencia, M; Sánchez, E | 1 |
Bradley-Guidry, C; Cutler, RE; Jones, K; Mitchell, HC; Sica, D; Smith, RD; Thompsen-Bell, S; Toto, RD; Videen, J | 1 |
Himeno, H; Hiroto, S; Minamisawa, K; Naruse, M; Shionoiri, H; Takasaki, I; Ueda, S | 1 |
Bambara, LM; Biasi, D; Caramaschi, P; Carletto, A | 1 |
Cicco, G; Pirrelli, A; van der Kleij, AJ; Vicenti, P | 1 |
Alli, C; Broccolino, M; Ferrari, S; Lombardo, M; Montemurro, L; Zaini, G; Zanni, D | 1 |
Zanchetti, A | 1 |
Collatina, S; Leonetti, G; Tosetti, A; Trimarco, B | 1 |
Plat, F; Saini, R | 1 |
Vetter, W | 1 |
Deedwania, PC | 1 |
Drozdov, VN; Ivleva, AIa; Kobalava, ZhD; Kotovskaia, IuV; Moiseev, VS; Moryleva, ON | 1 |
Greminger, P; Koch, J; Simeon-Dubach, D | 1 |
Fassbinder, W; Ziegler, J | 1 |
Blowers, DA; Edwards, C; Pover, GM | 1 |
Furberg, CD; Pahor, M; Psaty, BM | 1 |
Byington, RP; Di Mauro, P; Guarisco, R; Pahor, M; Strollo, F; Strollo, G; Tatti, P | 1 |
Califf, RM; Granger, CB | 1 |
Gerolimou, B; Hatzigakis, SM; Karmaniolas, KD; Kozanidou, G; Migdalis, IN | 1 |
Hatzizaharias, A; Krespi, P; Kyriakidis, M; Makris, T; Triposkiadis, F; Votteas, V | 1 |
Zamorski, MA | 1 |
Berdah, J; Guest, M; Salvador, M | 1 |
Sowers, JR | 1 |
Parving, HH | 1 |
Fang, TC; Huang, WC | 1 |
Pahor, M; Tatti, P | 1 |
Fasching, P; Gasic, S; Jilma, B; Kapiotis, S; Ludwig, C; Veitl, M; Wagner, OF | 1 |
Cheung, BM; Lau, CP | 1 |
Andersson, PE; Andrén, B; Haenni, A; Lithell, H; Reneland, R | 1 |
Ellsworth, A; Fink, KS | 1 |
Cook, ME; Thakur, V; Wallin, JD | 1 |
Fu, J; Kim, L; Lee, T; Ritchie, ME | 1 |
Intengan, HD; Li, JS; Schiffrin, EL; Thibault, G | 1 |
Blomberg, PJ; Long, A; Mochizuki, Y; Pandian, N; Rebeiz, E; Surks, HK | 1 |
Birkenhäger, WH; Fagard, RH; Staessen, JA | 1 |
Attias, J; Breslow, JL; Brodsky, S; Coleman, R; Hayek, T; Keidar, S; Smith, J | 1 |
Cordan, J; Ilcol, B; Serdar, A; Türel, B; Yesilbursa, D | 1 |
Gallardo, J; García-Robles, R; Rodríguez-García, JL; Serrano, M; Villa, E | 1 |
Estelberger, W; Holzer, H; Oettl, K; Reibnegger, G; Stoschitzky, K; Zitta, S; Zweiker, R | 1 |
Baleydier, A; Croce, I; Franconi, G; Girerd, X; Hanon, O; Mourad, JJ | 1 |
Anastasiadis, G; Gialeraki, AE; Hatzizacharias, AN; Krespi, PG; Kyriakidis, M; Makris, TK; Stavroulakis, GA; Triposkiadis, P | 1 |
Aydin, S; Dondurmaci, S; Ozaras, R; Oztekin, GE; Tahan, V; Turkmen, S; Uzun, H | 1 |
Cook, N; Lee, S; Ong, CS | 1 |
Baggio, G; Bond, MG; Collatina, S; Crepaldi, G; Gallus, GV; Mancia, G; Rubba, P; Sampieri, L; Serrotti, E; Veglia, F; Ventura, A; Zanchetti, A | 1 |
Davis, J; Hill, D; Lowenthal, DT; Williams, LS | 1 |
Frank, H; Globits, S; Hoffmann, U; Kostner, K; Loewe, C; Stefenelli, T | 1 |
Aljama, P; Aranda, P; Diez, J; Marin, R; Ruilope, LM; Segura, J | 1 |
Atamas, N; Dong, Y; Liao, WC; Shaffer, E; Wei, C; Zhou, H | 1 |
Applegate, WB; Cushman, WC; Deitcher, SR; Franse, LV; Johnson, KC; Kottke-Marchant, K; Pahor, M; Shorr, RI; Somes, GW; Tracy, RP | 1 |
Cech, J; Rosolová, H; Sefrna, F | 1 |
Bi, WF; Chang, NC; Lai, ZY; Lin, MS; Shih, CM; Wang, TC | 1 |
Weber, MA | 1 |
McTavish, D; Murdoch, D | 1 |
Boucher, CA; Christensen, DM; Higgins, J; Zusman, RM | 1 |
Aber, GM; Harding, P; Stonier, C | 1 |
Cushman, DW; DeForrest, JM; Harvey, C; Mitch, S; Petrillo, W; Powell, JR; Scalese, B; Waldron, TL | 1 |
Abboa-Offei, B; Seymour, AA; Swerdel, JN | 1 |
Frohlich, ED; Garavaglia, GE; Grossman, E; Messerli, FH; Oren, S | 1 |
Anderson, RJ; Duchin, KL; Gore, RD; Herman, TS; Michaels, RS; Nichola, PS; Nolen, TM; Wolfson, P; Wombolt, DG; Zusman, R | 1 |
Bochicchio, T; Bordes, J; Herrera-Acosta, J; Pérez-Grovas, H; Ron, O; Sandoval, G | 1 |
Backman, R; Forslund, T; Franzén, P | 1 |
Andersen, AR; Ibsen, H; Paulson, OB; Rasmussen, S; Strandgaard, S; Waldemar, G | 1 |
Cervenka, J; Dineen, M; O'Connor, DT; Sullivan, PA | 2 |
Cushman, DW; DeForrest, JM; Fung, WC; Grover, GJ; Harvey, CM; Mitch, SL; Scalese, RJ; Wang, FL | 1 |
14 review(s) available for fosinopril and Hypertension
Article | Year |
---|---|
Comparative Efficacy and Safety of Antihypertensive Agents for Adult Diabetic Patients with Microalbuminuric Kidney Disease: A Network Meta-Analysis.
Topics: Adult; Aged; Aged, 80 and over; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Bayes Theorem; Benzimidazoles; Biphenyl Compounds; Diabetes Mellitus, Type 2; Follow-Up Studies; Fosinopril; Humans; Hypertension; Indoles; Kidney Diseases; Middle Aged; Patient Safety; Probability; Randomized Controlled Trials as Topic; Tetrazoles; Treatment Outcome; Young Adult | 2017 |
Using ACE inhibitors appropriately.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Captopril; Cardiovascular Diseases; Clinical Trials as Topic; Contraindications; Diabetic Nephropathies; Drug Costs; Enalapril; Fosinopril; Heart Failure; Humans; Hypertension; Indoles; Isoquinolines; Lisinopril; Meta-Analysis as Topic; Myocardial Infarction; Perindopril; Quinapril; Ramipril; Renin-Angiotensin System; Risk; Tetrahydroisoquinolines; United States | 2002 |
[Hypertension combined with atherosclerotic lesions in carotid arteries: should angiotensin converting enzyme inhibitors be prescribed?].
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anticholesteremic Agents; Antihypertensive Agents; Atenolol; Calcium Channel Blockers; Carotid Artery Diseases; Carotid Artery, Common; Chlorthalidone; Drug Therapy, Combination; Female; Fosinopril; Humans; Hypertension; Male; Middle Aged; Pravastatin; Randomized Controlled Trials as Topic; Risk Factors; Time Factors; Ultrasonography; Vasodilator Agents; Verapamil | 2005 |
Microalbuminuria in type 2 diabetes and hypertension: a marker, treatment target, or innocent bystander?
Topics: Albuminuria; Antihypertensive Agents; Biomarkers; Blood Pressure; Cardiovascular Diseases; Clinical Trials as Topic; Cohort Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Fosinopril; Glomerular Filtration Rate; Humans; Hypertension; Prevalence; Proteinuria | 2008 |
ACE inhibitors: review of four new agents.
Topics: Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Fosinopril; Heart Failure; Humans; Hypertension; Isoquinolines; Quinapril; Ramipril; Tetrahydroisoquinolines | 1993 |
Metabolic effects of converting enzyme inhibitors: focus on the reduction of cholesterol and lipoprotein(a) by fosinopril.
Topics: Black People; Cholesterol; Diabetes Complications; Double-Blind Method; Fosinopril; Humans; Hypertension; Kidney Diseases; Lipoprotein(a); Proteinuria; Time Factors | 1993 |
Fosinopril: a reappraisal of its pharmacology and therapeutic efficacy in essential hypertension.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Fosinopril; Humans; Hypertension | 1996 |
Fosinopril. Clinical pharmacokinetics and clinical potential.
Topics: Absorption; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Drug Interactions; Female; Fosinopril; Heart Failure; Hemodynamics; Humans; Hypertension; Hypertrophy, Left Ventricular; Kidney; Kidney Diseases; Liver; Liver Diseases; Male; Myocardial Ischemia; Peritoneal Dialysis, Continuous Ambulatory; Renal Dialysis | 1997 |
The hypertensive patient with multiple risk factors: is treatment really so difficult?
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Animals; Anticholesteremic Agents; Antihypertensive Agents; Arteriosclerosis; Clinical Trials as Topic; Coronary Disease; Female; Fosinopril; Humans; Hydrochlorothiazide; Hypercholesterolemia; Hypertension; Male; Middle Aged; Pravastatin; Risk Factors | 1997 |
The progression from hypertension to heart failure.
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Disease Progression; Female; Fosinopril; Heart Failure; Humans; Hypertension; Hypertrophy, Left Ventricular; Kidney; Male; Middle Aged | 1997 |
Calcium antagonists and cardiovascular risk in diabetes.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Cardiovascular Diseases; Diabetes Complications; Drug Therapy, Combination; Europe; Fosinopril; Humans; Hypertension; Multicenter Studies as Topic; Randomized Controlled Trials as Topic | 1998 |
Dihydropyridine calcium-channel blockers for the treatment of hypertensive diabetic patients.
Topics: Amlodipine; Calcium Channel Blockers; Diabetic Angiopathies; Dihydropyridines; Enalapril; Fosinopril; Humans; Hypertension; Randomized Controlled Trials as Topic | 2000 |
Fosinopril: a new generation of angiotensin-converting enzyme inhibitors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Fosinopril; Humans; Hypertension | 1992 |
Fosinopril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in essential hypertension.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Fosinopril; Hemodynamics; Humans; Hypertension; Proline | 1992 |
85 trial(s) available for fosinopril and Hypertension
Article | Year |
---|---|
Antihypertensive drug treatment in white-coat hypertension: data from the Plaque HYpertension Lipid-Lowering Italian Study.
Topics: Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Fosinopril; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Lipids; White Coat Hypertension | 2022 |
Comparison of efficacy and safety between benidipine and hydrochlorothiazide in fosinopril-treated hypertensive patients with chronic kidney disease: protocol for a randomised controlled trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; China; Dihydropyridines; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Fosinopril; Glomerular Filtration Rate; Humans; Hydrochlorothiazide; Hypertension; Kidney; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Proteinuria; Renal Insufficiency, Chronic; Research Design; Treatment Outcome; Young Adult | 2017 |
Effects of a fixed-dose ACE inhibitor-diuretic combination on ambulatory blood pressure and arterial properties in isolated systolic hypertension.
Topics: Aged; Aged, 80 and over; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium Channel Blockers; Cross-Over Studies; Diuretics; Double-Blind Method; Drug Combinations; Female; Fosinopril; Humans; Hydrochlorothiazide; Hypertension; Indapamide; Male; Middle Aged; Monitoring, Ambulatory; Prospective Studies | 2008 |
Clinical variables, not RAAS polymorphisms, predict blood pressure response to ACE inhibitors in Sardinians.
Topics: Adult; Alleles; Angiotensin-Converting Enzyme Inhibitors; Anthropometry; Blood Pressure; Case-Control Studies; Chi-Square Distribution; Cohort Studies; Female; Fosinopril; Gene Frequency; Humans; Hypertension; Italy; Male; Middle Aged; Polymorphism, Genetic; Renin-Angiotensin System | 2008 |
Combination therapy with angiotensin-converting enzyme inhibitors and indapamide impairs glucose tolerance in Chinese hypertensive patients.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Glucose; Body Mass Index; China; Drug Therapy, Combination; Female; Fosinopril; Glucose Intolerance; Humans; Hypertension; Indapamide; Male; Middle Aged; Prospective Studies; Treatment Outcome; Waist Circumference; Waist-Hip Ratio | 2010 |
Statins, antihypertensive treatment, and blood pressure control in clinic and over 24 hours: evidence from PHYLLIS randomised double blind trial.
Topics: Aged; Anticholesteremic Agents; Antihypertensive Agents; Blood Pressure Determination; Drug Therapy, Combination; Female; Fosinopril; Humans; Hydrochlorothiazide; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertension; Italy; Male; Middle Aged; Pravastatin | 2010 |
Effect of combined angiotensin-converting enzyme and aldosterone inhibition on plasma plasminogen activator inhibitor type 1 levels in chronic hypertensive patients.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biomarkers; Chronic Disease; Diet, Sodium-Restricted; Down-Regulation; Drug Therapy, Combination; Female; Fibrinolysis; Fosinopril; Humans; Hypertension; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Plasminogen Activator Inhibitor 1; Renin; Spironolactone; Time Factors; Tissue Plasminogen Activator; Treatment Outcome | 2010 |
Effects of combination therapy with amlodipine and fosinopril administered at different times on blood pressure and circadian blood pressure pattern in patients with essential hypertension.
Topics: Amlodipine; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Chi-Square Distribution; Circadian Rhythm; Drug Therapy, Combination; Female; Fosinopril; Humans; Hypertension; Male; Middle Aged; Prospective Studies; Treatment Outcome | 2010 |
Visit-to-visit blood pressure variability is a strong predictor of cardiovascular events in hemodialysis: insights from FOSIDIAL.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Coronary Artery Disease; Female; Fosinopril; Humans; Hypertension; Incidence; Kidney Failure, Chronic; Linear Models; Male; Middle Aged; Models, Statistical; Office Visits; Peripheral Arterial Disease; Predictive Value of Tests; Renal Dialysis; Risk Factors; Stroke | 2012 |
The effects of losartan and fosinopril in hypertensive type 2 diabetic patients.
Topics: Adult; Alanine Transaminase; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Aspartate Aminotransferases; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diet, Diabetic; Dose-Response Relationship, Drug; Electrolytes; Female; Fosinopril; Humans; Hypertension; Hypoglycemic Agents; Insulin; Lipids; Losartan; Male; Middle Aged; Time Factors | 2002 |
Effects of amlodipine fosinopril combination on microalbuminuria in hypertensive type 2 diabetic patients.
Topics: Aged; Albuminuria; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Drug Combinations; Female; Fosinopril; Glycated Hemoglobin; Humans; Hypertension; Male; Middle Aged; Treatment Outcome | 2002 |
Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism.
Topics: Aldosterone; Amlodipine; Antihypertensive Agents; Atenolol; Biphenyl Compounds; Confounding Factors, Epidemiologic; Diagnostic Tests, Routine; Doxazosin; False Negative Reactions; False Positive Reactions; Fosinopril; Humans; Hyperaldosteronism; Hypertension; Irbesartan; Middle Aged; Predictive Value of Tests; Renin; Renin-Angiotensin System; Sensitivity and Specificity; Tetrazoles; Tomography, X-Ray Computed | 2002 |
[FLAG--a program of achievability of target blood pressure levels during treatment of patients with hypertension with fosinopril].
Topics: Adolescent; Aged; Angiotensin-Converting Enzyme Inhibitors; Female; Fosinopril; Humans; Hypertension; Male; Middle Aged; Treatment Outcome | 2002 |
[Comparison of the antihypertensive activity of fosinopril and irbesartan].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Drug Therapy, Combination; Female; Fosinopril; Humans; Hydrochlorothiazide; Hypertension; Irbesartan; Male; Middle Aged; Renin-Angiotensin System; Tetrazoles; Treatment Outcome | 2002 |
A prospective, randomized, open labeled crossover trial of fosinopril and theophylline in post renal transplant erythrocytosis.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Azathioprine; Biomarkers; Blood Pressure; Blood Urea Nitrogen; Creatinine; Cross-Over Studies; Cyclosporine; Fosinopril; Hematocrit; Hemoglobins; Humans; Hypertension; Immunosuppressive Agents; Kidney Transplantation; Middle Aged; Polycythemia; Postoperative Complications; Potassium; Prednisone; Prospective Studies; Theophylline; Treatment Outcome; Vasodilator Agents | 2003 |
Comparative metabolic effects of hydrochlorothiazide and indapamide in hypertensive diabetic patients receiving ACE inhibitor therapy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Cross-Over Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diuretics; Drug Therapy, Combination; Female; Fosinopril; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Indapamide; Male; Middle Aged; Prospective Studies; Single-Blind Method; Sodium Chloride Symporter Inhibitors | 2003 |
Post-exercise reduction in blood pressure in hypertensive subjects: effects of angiotensin converting enzyme inhibition.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Flow Velocity; Blood Pressure; Cardiac Output; Combined Modality Therapy; Double-Blind Method; Exercise Therapy; Fosinopril; Humans; Hypertension; Male; Plasma Volume; Stroke Volume; Vascular Resistance | 1993 |
Is the extrapolated adult dose of fosinopril safe and effective in treating hypertensive children?
Topics: Adolescent; Age Factors; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Body Surface Area; Child; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fosinopril; Headache; Humans; Hypertension; Male; Prodrugs; Prospective Studies; Treatment Outcome | 2004 |
Comparative effects of fosinopril and irbesartan on hematopoiesis in essential hypertensives.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Biphenyl Compounds; Erythrocyte Count; Female; Follow-Up Studies; Fosinopril; Hematopoiesis; Hemoglobins; Humans; Hypertension; Irbesartan; Male; Middle Aged; Tetrazoles; Time Factors | 2004 |
Different effects of antihypertensive regimens based on fosinopril or hydrochlorothiazide with or without lipid lowering by pravastatin on progression of asymptomatic carotid atherosclerosis: principal results of PHYLLIS--a randomized double-blind trial.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Anticholesteremic Agents; Antihypertensive Agents; Carotid Stenosis; Disease Progression; Diuretics; Drug Therapy, Combination; Female; Fosinopril; Humans; Hydrochlorothiazide; Hypercholesterolemia; Hypertension; Male; Middle Aged; Pravastatin; Sodium Chloride Symporter Inhibitors | 2004 |
Effects of amlodipine and fosinopril on heart rate variability and left ventricular mass in mild-to-moderate essential hypertension.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Electrocardiography; Female; Fosinopril; Heart Rate; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged | 2005 |
[Applicability of fozinopril for correction of basic manifestations of metabolic syndrome in women with arterial hypertension].
Topics: Aged; Antihypertensive Agents; Blood Pressure; Female; Fosinopril; Humans; Hypertension; Metabolic Syndrome; Middle Aged | 2005 |
[Effects of ACE inhibitor fosinopril on a 24-h profile of arterial pressure in hypertensive patients with obesity and hypercholesterolemia].
Topics: Adrenergic beta-Antagonists; Adult; Angiotensin-Converting Enzyme Inhibitors; Drug Administration Schedule; Female; Fosinopril; Humans; Hypercholesterolemia; Hypertension; Male; Metoprolol; Middle Aged; Obesity | 2005 |
Prevention of cardiovascular events in end-stage renal disease: results of a randomized trial of fosinopril and implications for future studies.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cardiovascular Diseases; Clinical Protocols; Confidence Intervals; Data Interpretation, Statistical; Female; Forecasting; Fosinopril; Humans; Hypertension; Kidney Failure, Chronic; Male; Placebos; Renal Dialysis; Risk Factors; Time Factors; Treatment Outcome | 2006 |
Racial differences are seen in blood pressure response to fosinopril in hypertensive children.
Topics: Adolescent; Angiotensin-Converting Enzyme Inhibitors; Black or African American; Body Mass Index; Child; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fosinopril; Humans; Hypertension; Male; Prospective Studies; White People | 2006 |
Clinical study on effect of Garlicin in stabilizing the carotid artery atherosclerotic plaque in patients with primary hypertension and coronary artery disease.
Topics: Aged; Allyl Compounds; Antihypertensive Agents; Blood Pressure; C-Reactive Protein; Carotid Artery Diseases; Coronary Artery Disease; Disulfides; Female; Fosinopril; Humans; Hypertension; Intercellular Adhesion Molecule-1; Male; Middle Aged; Ultrasonography | 2006 |
Evaluation of antihypertensive effects of once-a-day isradipine and fosinopril: a double-blind crossover study by means of ambulatory blood pressure monitoring.
Topics: Administration, Oral; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Cross-Over Studies; Double-Blind Method; Female; Fosinopril; Heart Rate; Humans; Hypertension; Isradipine; Male; Middle Aged | 1995 |
Different effects of fosinopril and atenolol on wave reflections in hypertensive patients.
Topics: Adult; Aged; Atenolol; Blood Pressure; Double-Blind Method; Female; Fosinopril; Humans; Hypertension; Male; Middle Aged | 1995 |
Comparative effects of fosinopril and nifedipine on regression of left ventricular hypertrophy in hypertensive patients: a double-blind study.
Topics: Blood Pressure; Blood Pressure Determination; Double-Blind Method; Drug Therapy, Combination; Echocardiography; Female; Fosinopril; Humans; Hydrochlorothiazide; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Nifedipine | 1995 |
Effect of fosinopril on cardiac and metabolic parameters in patients with NIDDM.
Topics: Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 2; Double-Blind Method; Echocardiography, Doppler; Female; Fosinopril; Heart; Humans; Hypertension; Insulin; Lipids; Male; Middle Aged; Multivariate Analysis | 1994 |
Metabolic effects of long-term angiotensin-converting enzyme inhibition with fosinopril in patients with essential hypertension: relationship to angiotensin-converting enzyme inhibition.
Topics: Adolescent; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Blood Pressure; Female; Fosinopril; Glucose Tolerance Test; Heart Rate; Humans; Hypertension; Insulin Resistance; Lipids; Lipoproteins; Male; Middle Aged; Peptidyl-Dipeptidase A | 1994 |
[Treatment of mild and moderate hypertension with fosinopril. Comparison of adverse effects with other antihypertensive agents].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Antihypertensive Agents; Female; Fosinopril; Humans; Hypertension; Male; Middle Aged | 1994 |
The pharmacokinetics and pharmacodynamics of fosinopril in haemodialysis patients.
Topics: Administration, Oral; Adult; Biological Availability; Biotransformation; Feces; Female; Fosinopril; Humans; Hypertension; Male; Middle Aged; Renal Dialysis | 1993 |
Plaque Hypertension Lipid-Lowering Italian Study (PHYLLIS): a protocol for non-invasive evaluation of carotid atherosclerosis in hypercholesterolaemic hypertensive subjects.
Topics: Aged; Arteriosclerosis; Carotid Artery Diseases; Clinical Protocols; Double-Blind Method; Female; Fosinopril; Humans; Hypercholesterolemia; Hypertension; Italy; Male; Middle Aged; Pravastatin; Ultrasonography | 1993 |
Effects of fosinopril and hydrochlorothiazide on cerebral perfusion in uncomplicated essential hypertension.
Topics: Blood Pressure; Cerebrovascular Circulation; Double-Blind Method; Female; Fosinopril; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Organotechnetium Compounds; Oximes; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon | 1993 |
[Fosinopril in a daily single dose in mild and moderate hypertension. Brazilian multicenter study].
Topics: Adolescent; Adult; Aged; Blood Pressure; Brazil; Drug Administration Schedule; Female; Fosinopril; Humans; Hypertension; Male; Middle Aged; Time Factors | 1993 |
Combined versus single effect of fosinopril and hydrochlorothiazide in hypertensive patients.
Topics: Adult; Aged; Double-Blind Method; Drug Therapy, Combination; Female; Fosinopril; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Placebos | 1994 |
Metabolic effects of converting enzyme inhibitors: focus on the reduction of cholesterol and lipoprotein(a) by fosinopril.
Topics: Black People; Cholesterol; Diabetes Complications; Double-Blind Method; Fosinopril; Humans; Hypertension; Kidney Diseases; Lipoprotein(a); Proteinuria; Time Factors | 1993 |
Disparate cardiovascular response to stress tests during isradipine and fosinopril therapy.
Topics: Cardiovascular System; Exercise Test; Female; Fosinopril; Hemodynamics; Humans; Hypertension; Isradipine; Male; Middle Aged | 1993 |
Fosinopril monotherapy: relationship between blood pressure reduction and time of administration.
Topics: Adult; Aged; Blood Pressure; Double-Blind Method; Drug Tolerance; Female; Fosinopril; Humans; Hypertension; Male; Middle Aged; Placebos; Single-Blind Method; Supine Position; Time Factors | 1993 |
Efficacy and safety of fosinopril/hydrochlorothiazide combinations on ambulatory blood pressure profiles in hypertension. Fosinopril/Hydrochlorothiazide Investigators.
Topics: Adolescent; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Female; Fosinopril; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged | 1996 |
[Antihypertensive effect of fosinopril in mild hypertension].
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Female; Fosinopril; Humans; Hypertension; Male; Middle Aged; Severity of Illness Index | 1996 |
Fosinopril versus enalapril in the treatment of hypertension: a double-blind study in 195 patients.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Enalapril; Female; Fosinopril; Humans; Hypertension; Male; Middle Aged | 1996 |
Permanent blood pressure control over the 24 h by trandolapril.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Enalapril; Fosinopril; Humans; Hypertension; Indoles; Middle Aged | 1995 |
Albuminuria and transferrinuria in essential hypertension. Effects of antihypertensive therapy.
Topics: Adult; Albuminuria; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Female; Fosinopril; Humans; Hypertension; Male; Middle Aged; Prospective Studies; Regression Analysis; Transferrin | 1996 |
Use of the factorial design and quadratic response surface models to evaluate the fosinopril and hydrochlorothiazide combination therapy in hypertension.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Double-Blind Method; Drug Therapy, Combination; Female; Fosinopril; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Models, Statistical | 1997 |
The alterations in insulin sensitivity during angiotensin converting enzyme inhibitor treatment are related to changes in the calcium/magnesium balance.
Topics: Adolescent; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium; Captopril; Double-Blind Method; Enalapril; Female; Fosinopril; Humans; Hypertension; Insulin; Lisinopril; Magnesium; Male; Middle Aged | 1997 |
Inhibitor index: a novel method for measuring pharmacological inhibition of angiotensin-converting enzyme.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Cardiology; Double-Blind Method; Female; Fluorometry; Fosinopril; Humans; Hypertension; Indoles; Male; Middle Aged; Muscle, Skeletal; Peptidyl-Dipeptidase A | 1997 |
Racial differences in the renal response to blood pressure lowering during chronic angiotensin-converting enzyme inhibition: a prospective double-blind randomized comparison of fosinopril and lisinopril in older hypertensive patients with chronic renal in
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Black People; Double-Blind Method; Female; Fosinopril; Glomerular Filtration Rate; Humans; Hypertension; Infant, Newborn; Kidney; Kidney Failure, Chronic; Lisinopril; Male; Middle Aged; Prospective Studies | 1997 |
Long-term effects of angiotensin-converting enzyme inhibitors and calcium antagonists on the right and left ventricles in essential hypertension.
Topics: Adult; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure Determination; Calcium Channel Blockers; Echocardiography; Female; Fosinopril; Humans; Hypertension; Male; Middle Aged; Myocardium; Prospective Studies; Ventricular Function | 1997 |
The hypertensive patient with multiple risk factors: is treatment really so difficult?
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Animals; Anticholesteremic Agents; Antihypertensive Agents; Arteriosclerosis; Clinical Trials as Topic; Coronary Disease; Female; Fosinopril; Humans; Hydrochlorothiazide; Hypercholesterolemia; Hypertension; Male; Middle Aged; Pravastatin; Risk Factors | 1997 |
An effective approach for treating elderly patients with isolated systolic hypertension: results of an Italian multicenter study with fosinopril.
Topics: Administration, Oral; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Chlorthalidone; Double-Blind Method; Female; Fosinopril; Heart Rate; Humans; Hypertension; Italy; Male; Middle Aged; Systole | 1997 |
Management of hypertension: the role of combination therapy.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Type 2; Diuretics; Drug Administration Schedule; Drug Therapy, Combination; Fosinopril; Humans; Hydrochlorothiazide; Hypertension; Sodium Chloride Symporter Inhibitors | 1997 |
Treatment of senile hypertension: the Fosinopril in Old Patients Study (FOPS).
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cough; Creatinine; Drug Administration Schedule; Female; Fosinopril; Humans; Hypertension; Kidney Diseases; Male; Middle Aged | 1997 |
[Fosinorm in the treatment of essential hypertension with a metabolic syndrome].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Chronic Disease; Diuretics; Drug Therapy, Combination; Female; Fosinopril; Humans; Hydrochlorothiazide; Hyperlipidemias; Hypertension; Male; Middle Aged; Sodium Chloride Symporter Inhibitors; Syndrome; Time Factors | 1997 |
Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Glucose; Blood Pressure; Body Mass Index; Calcium Channel Blockers; Cholesterol, HDL; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Follow-Up Studies; Fosinopril; Glycated Hemoglobin; Humans; Hypertension; Lipids; Male; Middle Aged; Prospective Studies; Time Factors | 1998 |
Hypertension and diabetes and the Fosinopril versus Amlodipine Cardiovascular Events Trial (FACET). More ammunition against surrogate end points.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Clinical Protocols; Diabetic Angiopathies; Fosinopril; Humans; Hypertension; Models, Biological; Reproducibility of Results | 1998 |
Effect of fosinopril sodium on early carotid atherosclerosis in diabetic patients with hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arteriosclerosis; Carotid Arteries; Carotid Artery Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diet Therapy; Female; Fosinopril; Humans; Hypertension; Male; Middle Aged; Tunica Intima; Tunica Media; Ultrasonography | 1997 |
Insulin receptor number in arterial hypertension: response to treatment with fosinopril or atenolol.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Pressure; Fosinopril; Humans; Hypertension; Male; Middle Aged; Receptor, Insulin; Reference Values; Treatment Outcome | 1998 |
CCBs vs ACE inhibitors in patients with diabetes.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Follow-Up Studies; Fosinopril; Humans; Hypertension; Risk Factors; Treatment Outcome | 1998 |
[Study of the efficacy and safety of fosinopril in general practice in 19,435 hypertensive patients (FLIGHT Study)].
Topics: Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Fosinopril; Humans; Hypertension; Middle Aged; Quality of Life; Treatment Outcome | 1998 |
Comorbidity of hypertension and diabetes: the fosinopril versus amlodipine cardiovascular events trial (FACET)
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Confounding Factors, Epidemiologic; Diabetes Complications; Fosinopril; Humans; Hypertension; Life Style; Treatment Outcome | 1998 |
The Fosinopril versus Amlodipine Cardiovascular Events Trial (FACET) and combination therapies.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Drug Combinations; Enalapril; Follow-Up Studies; Fosinopril; Heart Diseases; Humans; Hypertension; Nisoldipine; Prospective Studies; Reproducibility of Results; Risk Factors; Treatment Outcome | 1999 |
Fosinopril decreases levels of soluble vascular cell adhesion molecule-1 in borderline hypertensive type II diabetic patients with microalbuminuria.
Topics: Adult; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 2; E-Selectin; Female; Follow-Up Studies; Fosinopril; Glycated Hemoglobin; Humans; Hypertension; Intercellular Adhesion Molecule-1; Male; Middle Aged; Peptidyl-Dipeptidase A; Plasminogen Activator Inhibitor 1; Prospective Studies; Tissue Plasminogen Activator; Treatment Outcome; Vascular Cell Adhesion Molecule-1 | 1999 |
Fosinopril reduces left ventricular mass in untreated hypertensive patients: a controlled trial.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Body Weight; Double-Blind Method; Echocardiography; Electrocardiography; Electrolytes; Female; Fosinopril; Heart Rate; Hemodynamics; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Peptidyl-Dipeptidase A; Placebos; Urine | 1999 |
Skeletal muscle angiotensin-converting enzyme and its relationship to blood pressure in primary hypertension and healthy elderly men.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Pressure; Cross-Sectional Studies; Double-Blind Method; Feedback; Female; Fosinopril; Humans; Hypertension; Male; Middle Aged; Muscle, Skeletal; Peptidyl-Dipeptidase A | 1999 |
Antihypertensive effect of the combination of fosinopril and HCTZ is resistant to interference by nonsteroidal antiinflammatory drugs.
Topics: Acetaminophen; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Blood Pressure; Butanones; Creatinine; Dinoprostone; Diuretics; Drug Interactions; Drug Therapy, Combination; Female; Fosinopril; Glomerular Filtration Rate; Humans; Hydrochlorothiazide; Hypertension; Ibuprofen; Middle Aged; Nabumetone; Renal Plasma Flow; Sodium; Sodium Chloride Symporter Inhibitors; Sulindac; Thromboxane B2 | 1999 |
Effects of fosinopril treatment on blood pressure during physical and mental stress test in essential hypertension.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Exercise Test; Female; Fosinopril; Heart Rate; Humans; Hypertension; Male; Middle Aged; Stress, Psychological | 1999 |
Prostacyclin: its pathogenic role in essential hypertension and the class effect of ACE inhibitors on prostaglandin metabolism.
Topics: 6-Ketoprostaglandin F1 alpha; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Case-Control Studies; Enalapril; Epoprostenol; Female; Fosinopril; Humans; Hypertension; Male; Middle Aged; Prostaglandins; Ramipril | 1999 |
Dynamic renal function testing by compartmental analysis: assessment of renal functional reserve in essential hypertension.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Carbazoles; Carvedilol; Dietary Proteins; Female; Fosinopril; Glomerular Filtration Rate; Humans; Hypertension; Kidney; Kidney Function Tests; Male; Middle Aged; Oligosaccharides; p-Aminohippuric Acid; Propanolamines; Reference Values; Renal Circulation; Vascular Resistance | 2000 |
[The estimation of cardiovascular risk in hypertensive patients is not modified by management of the hypertension].
Topics: Adult; Aged; Analysis of Variance; Antihypertensive Agents; Blood Pressure; Cholesterol, HDL; Drug Combinations; Female; Follow-Up Studies; Fosinopril; Heart Diseases; Humans; Hydrochlorothiazide; Hypertension; Logistic Models; Male; Middle Aged; Odds Ratio; Risk Factors; Sex Factors; Smoking; Treatment Outcome | 2000 |
Increased urinary NAG excretion in hypertensives can decline with antihypertensive treatment.
Topics: Acetylglucosamine; Adult; Aged; Antihypertensive Agents; Biomarkers; Creatinine; Diastole; Female; Fosinopril; Glomerular Filtration Rate; Humans; Hypertension; Male; Middle Aged; Potassium; Systole | 2000 |
Systolic and pulse blood pressures (but not diastolic blood pressure and serum cholesterol) are associated with alterations in carotid intima-media thickness in the moderately hypercholesterolaemic hypertensive patients of the Plaque Hypertension Lipid Lo
Topics: Angiotensin-Converting Enzyme Inhibitors; Anticholesteremic Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Carotid Arteries; Cholesterol; Disease Progression; Drug Therapy, Combination; Female; Fosinopril; Heart Rate; Humans; Hypercholesterolemia; Hypertension; Italy; Male; Middle Aged; Pravastatin; Systole; Tunica Intima; Ultrasonography | 2001 |
Effects of fosinopril or sustained-release verapamil on blood pressure and serum catecholamine concentrations in elderly hypertensive men.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Blood Pressure Determination; Delayed-Action Preparations; Double-Blind Method; Epinephrine; Fosinopril; Humans; Hypertension; Male; Middle Aged; Norepinephrine; Verapamil | 2000 |
The effects of ACE inhibitor therapy on left ventricular myocardial mass and diastolic filling in previously untreated hypertensive patients: a cine MRI study.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Cardiac Volume; Diastole; Female; Follow-Up Studies; Fosinopril; Heart Ventricles; Hemodynamics; Humans; Hypertension; Hypertrophy, Left Ventricular; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Myocardium; Prospective Studies; Ventricular Dysfunction, Left | 2001 |
A random comparison of fosinopril and nifedipine GITS in patients with primary renal disease.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium Channel Blockers; Delayed-Action Preparations; Female; Fosinopril; Humans; Hypertension; Kidney; Kidney Diseases; Male; Middle Aged; Nifedipine; Prospective Studies | 2001 |
Fosinopril versus amlodipine comparative treatments study: a randomized trial to assess effects on plasminogen activator inhibitor-1.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Blood Pressure; Calcium Channel Blockers; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Fosinopril; Humans; Hypertension; Male; Middle Aged; Plasminogen Activator Inhibitor 1 | 2002 |
[Effectiveness and tolerance of fosinopril in the treatment of arterial hypertension of mild and medium severity].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Diuretics; Drug Therapy, Combination; Female; Fosinopril; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Prospective Studies; Sodium Chloride Symporter Inhibitors | 2001 |
Fosinopril improves left ventricular diastolic function in young mildly hypertensive patients without hypertrophy.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Data Interpretation, Statistical; Dose-Response Relationship, Drug; Echocardiography, Doppler; Female; Fosinopril; Humans; Hydralazine; Hydrochlorothiazide; Hypertension; Male; Reference Values; Time Factors; Ventricular Function, Left | 2002 |
Fosinopril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in essential hypertension.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Fosinopril; Hemodynamics; Humans; Hypertension; Proline | 1992 |
Effects of fosinopril on cardiac function in patients with hypertension. Radionuclide assessment of left ventricular systolic and diastolic performance.
Topics: Adolescent; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Diastole; Double-Blind Method; Female; Fosinopril; Heart; Heart Rate; Humans; Hypertension; Male; Middle Aged; Proline; Radionuclide Angiography; Renin-Angiotensin System; Systole; Ventricular Function, Left | 1992 |
Once-daily fosinopril in the treatment of hypertension.
Topics: Antihypertensive Agents; Blood Pressure; Chlorthalidone; Double-Blind Method; Drug Therapy, Combination; Female; Fosinopril; Humans; Hypertension; Male; Proline; Supination; Time Factors | 1991 |
Comparison of fosinopril and hydrochlorothiazide in patients with mild to moderate hypertension.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Double-Blind Method; Female; Fosinopril; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Proline; Renin-Angiotensin System | 1991 |
Fosenopril, an angiotensin-converting enzyme inhibitor, and propranolol: comparative effects at rest and exercise on blood pressure, hormonal variables, and plasma potassium in essential hypertension.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Double-Blind Method; Exercise; Fosinopril; Hormones; Humans; Hypertension; Male; Middle Aged; Potassium; Proline; Propranolol; Random Allocation; Renin; Rest | 1989 |
Effects of fosenopril, a once-daily angiotensin-converting enzyme inhibitor, on resting and exercise-induced changes of blood pressure, hormonal variables, and plasma potassium in essential hypertension.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Drug Administration Schedule; Fosinopril; Hormones; Humans; Hypertension; Middle Aged; Physical Exertion; Potassium; Proline; Renin; Rest | 1988 |
67 other study(ies) available for fosinopril and Hypertension
Article | Year |
---|---|
Dual metalloprotease inhibitors: mercaptoacetyl-based fused heterocyclic dipeptide mimetics as inhibitors of angiotensin-converting enzyme and neutral endopeptidase.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Cardiovascular Agents; Cyclic GMP; Enzyme Inhibitors; Heart Failure; Hypertension; Macaca fascicularis; Neprilysin; Pyridines; Rats; Renin; Sodium; Thiazepines | 1997 |
Early Renin-angiotensin System Blockade Improved Short-term and Longterm Renal Outcomes in Systemic Lupus Erythematosus Patients with Antiphospholipid-associated Nephropathy.
Topics: Adult; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antibodies, Antiphospholipid; Biopsy; Chi-Square Distribution; Disease Progression; Female; Follow-Up Studies; Fosinopril; Glomerular Filtration Rate; Humans; Hypertension; Kidney; Logistic Models; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Middle Aged; Proportional Hazards Models; Proteinuria; Renin-Angiotensin System; Risk Factors; Statistics, Nonparametric; Treatment Outcome; Young Adult | 2018 |
Effect of fosinopril on the transient outward potassium current of hypertrophied left ventricular myocardium in the spontaneously hypertensive rat.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Fosinopril; Hypertension; Hypertrophy, Left Ventricular; Male; Myocardium; Potassium Channels; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 2014 |
Effects of antihypertensive treatment on cardiovascular autonomic control: a prospective study.
Topics: Antihypertensive Agents; Atenolol; Atrial Fibrillation; Autonomic Nervous System; Cohort Studies; Enalapril; Female; Fosinopril; Humans; Hypertension; Male; Metoprolol; Middle Aged; Prospective Studies | 2014 |
[The use of complex tools ezetimibe, hepadyfu fosinopril and correction of blood pressure and endothelial dysfunction in patients with nonalcoholic steatohepatitis and essential hypertension stage II].
Topics: Adenine; Anticholesteremic Agents; Azetidines; Carnitine; Drug Combinations; Endothelium, Vascular; Essential Hypertension; Ezetimibe; Fosinopril; Humans; Hypertension; Non-alcoholic Fatty Liver Disease; Obesity; Vascular Diseases | 2014 |
[Effects of fosinopril and losartan on the expression of Toll- like receptor 4 in renal tubular epithelia cells].
Topics: Animals; Cell Line; Epithelial Cells; Fosinopril; Hypertension; Kidney Diseases; Kidney Tubules; Losartan; Rats; RNA Interference; RNA, Messenger; Toll-Like Receptor 4 | 2008 |
[The use of monopril in elderly patients with arterial hypertension and coronary heart disease].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Coronary Disease; Dose-Response Relationship, Drug; Electrocardiography; Female; Follow-Up Studies; Fosinopril; Humans; Hypertension; Male; Surveys and Questionnaires; Treatment Outcome | 2009 |
Fosinopril and valsartan intervention in gene expression of Klotho, MMP-9, TIMP-1, and PAI-1 in the kidney of spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Fibrosis; Fosinopril; Glucuronidase; Hypertension; Kidney; Klotho Proteins; Male; Matrix Metalloproteinase 9; Plasminogen Activator Inhibitor 1; Random Allocation; Rats; Rats, Inbred SHR; Rats, Inbred WKY; RNA, Messenger; Tetrazoles; Tissue Inhibitor of Metalloproteinase-1; Valine; Valsartan | 2010 |
Effects of fosinopril and losartan on renal Klotho expression and oxidative stress in spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Fosinopril; Glucuronidase; Hypertension; Kidney; Klotho Proteins; Losartan; Male; Oxidative Stress; Rats; Rats, Inbred SHR; Rats, Inbred WKY; RNA, Messenger | 2011 |
Fosinopril and losartan regulate klotho gene and nicotinamide adenine dinucleotide phosphate oxidase expression in kidneys of spontaneously hypertensive rats.
Topics: Animals; Disease Progression; Fosinopril; Gene Expression Regulation, Enzymologic; Glucuronidase; Hypertension; Kidney; Klotho Proteins; Losartan; Male; NADPH Oxidases; Random Allocation; Rats; Rats, Inbred SHR; Rats, Inbred WKY; RNA, Messenger | 2011 |
Hemodynamic and humoral effects of vasopeptidase inhibition in canine hypertension.
Topics: Adrenomedullin; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Dogs; Fosinopril; Hemodynamics; Hypertension; Kinetics; Male; Neprilysin; Peptides; Protease Inhibitors; Pyridines; Thiazepines; Vasoconstrictor Agents | 2002 |
Apoptosis, myocardial fibrosis and angiotensin II in the left ventricle of hypertensive rats treated with fosinopril or losartan.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Apoptosis; Blood Pressure; Fibrosis; Fosinopril; Hypertension; Hypertrophy, Left Ventricular; Losartan; Myocardium; Rats; Rats, Inbred SHR | 2002 |
[Changes of distensibility of the aorta in elderly patients during long-term therapy with various classes of hypotensive drugs (magnetic resonance tomography data)].
Topics: Adrenergic beta-Antagonists; Age Factors; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Aorta; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Data Interpretation, Statistical; Diuretics; Elasticity; Female; Fosinopril; Humans; Hypertension; Indapamide; Magnetic Resonance Imaging; Male; Metoprolol; Middle Aged; Models, Biological; Risk Factors; Time Factors | 2002 |
[Contrast of losartan, fosinopril and amlodipine on cardiomyocyte apoptosis and left ventricular remolding in hypertensive rats].
Topics: Amlodipine; Animals; Antihypertensive Agents; Apoptosis; Cardiotonic Agents; Female; Fosinopril; Hypertension; Losartan; Male; Myocytes, Cardiac; Random Allocation; Rats; Rats, Inbred SHR; Ventricular Remodeling | 2001 |
[Effects of lorsartan, fosinopril on myocardial fibrosis, angiotensin II and cardiac remolding in hypertensive rats].
Topics: Angiotensin II; Animals; Antihypertensive Agents; Fibrosis; Fosinopril; Hypertension; Losartan; Male; Myocardium; Random Allocation; Rats; Rats, Inbred SHR; Ventricular Remodeling | 2001 |
The effect and mechanism of forsinopril on ventricular hypertrophy of SHR and left ventricular pressure overloading rat.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Female; Fosinopril; Hypertension; Hypertrophy, Left Ventricular; Male; Myocardium; Random Allocation; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Transforming Growth Factor beta | 2002 |
Acute visual loss after initiation of antihypertensive therapy: case report.
Topics: Acute Disease; Antihypertensive Agents; Blindness; Blood Pressure; Drug Therapy, Combination; Fosinopril; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Retinal Artery Occlusion; Treatment Outcome; Visual Acuity | 2003 |
Effect of dual angiotensin converting enzyme/neutral endopeptidase inhibition, angiotensin converting enzyme inhibition, or AT1 antagonism on coronary microvasculature in spontaneously hypertensive rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Arterioles; Biphenyl Compounds; Blood Pressure; Capillaries; Coronary Circulation; Drug Therapy, Combination; Fosinopril; Hypertension; Irbesartan; Male; Myocytes, Cardiac; Neprilysin; Pyridines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetrazoles; Thiazepines | 2003 |
Introduction to monitoring. What is what you prescribed actually doing?
Topics: Acetaminophen; Aged; Aspirin; Australia; Celecoxib; Drug Interactions; Drug Therapy, Combination; Family Practice; Female; Fosinopril; Humans; Hydrochlorothiazide; Hypertension; Monitoring, Physiologic; Osteoarthritis, Knee; Pyrazoles; Risk Assessment; Sensitivity and Specificity; Stroke; Sulfonamides | 2003 |
Cardiorenal protective effects of vasopeptidase inhibition with omapatrilat in hypertensive transgenic (mREN-2)27 rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Genetically Modified; Antihypertensive Agents; Atrial Natriuretic Factor; Biomarkers; Blood Pressure; Body Weight; Cardiomegaly; Disease Models, Animal; Dose-Response Relationship, Drug; Fosinopril; Hypertension; Kidney; Male; Models, Cardiovascular; Neprilysin; Pyridines; Rats; Renin; Statistics as Topic; Survival Analysis; Systole; Thiazepines; Time Factors; Treatment Outcome | 2004 |
Systemic contact dermatitis due to captopril without cross-sensitivity to fosinopril, quinapril and benazepril.
Topics: Administration, Oral; Aged; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Captopril; Dermatitis, Contact; Female; Fosinopril; Humans; Hypertension; Quinapril; Skin Tests; Tetrahydroisoquinolines | 2004 |
Possible induction of diabetes by treatment of hypertension with indapamide (with four case reports).
Topics: Adult; Antihypertensive Agents; Blood Glucose; Diabetes Mellitus; Drug Therapy, Combination; Female; Fosinopril; Humans; Hypertension; Indapamide; Male; Middle Aged; Time Factors | 2004 |
Therapeutic conversion from fosinopril to benazepril at a Veterans Affairs medical center.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Fosinopril; Glomerular Filtration Rate; Hospitals, Veterans; Humans; Hypertension; Potassium; Retrospective Studies | 2006 |
Primary hyperaldosteronism in a patient with end-stage renal disease.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Follow-Up Studies; Fosinopril; Humans; Hyperaldosteronism; Hypertension; Kidney Failure, Chronic; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Renal Dialysis; Renin; Spironolactone | 2007 |
[Evolution of the bone mass of hypertense menopausal women in treatment with fosinopril].
Topics: Absorptiometry, Photon; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Bone Density; Cohort Studies; Female; Fosinopril; Humans; Hypertension; Menopause; Middle Aged; Prospective Studies | 2006 |
[Comparative evaluation of the influence of sulfhydryl and phosphate ACE inhibitors on thrombocyte aggregation in patients suffering from atrerial hypertension with metabolic syndrome].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Female; Fosinopril; Humans; Hypertension; Male; Metabolic Syndrome; Platelet Activating Factor | 2007 |
Effects of low and high doses of fosinopril on the structure and function of resistance arteries.
Topics: Acetylcholine; Analysis of Variance; Animals; Blood Pressure; Endothelium, Vascular; Fosinopril; Heart; Heart Rate; Hypertension; Mesenteric Arteries; Potassium; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tunica Media; Vascular Resistance | 1995 |
[Evaluation of the total hepatic function after treatment with fosinopril in hypertensive patients with liver cirrhosis].
Topics: Fosinopril; Humans; Hypertension; Liver; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged | 1994 |
Serial echocardiographic-Doppler assessment of left ventricular geometry and function in rats with pressure-overload hypertrophy. Chronic angiotensin-converting enzyme inhibition attenuates the transition to heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiomegaly; Diastole; Echocardiography; Fosinopril; Heart Failure; Hemodynamics; Hypertension; Male; Rats; Rats, Wistar; Systole; Time Factors; Ventricular Function, Left | 1995 |
[Drug of the month. fosinopril (Fosinil)].
Topics: Angiotensin-Converting Enzyme Inhibitors; Fosinopril; Humans; Hypertension | 1994 |
Cough induced by quinapril with resolution after changing to fosinopril.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Cough; Female; Fosinopril; Humans; Hypertension; Isoquinolines; Quinapril; Tetrahydroisoquinolines | 1994 |
Lack of efficacy of angiotensin-converting enzyme inhibitors in reducing interdialytic weight gain.
Topics: Angiotensin-Converting Enzyme Inhibitors; Black People; Captopril; Enalapril; Fosinopril; Humans; Hypertension; Kidney Failure, Chronic; Middle Aged; Renal Dialysis; Retrospective Studies; Weight Gain | 1994 |
Angiotensin-converting enzyme inhibition prolongs survival and modifies the transition to heart failure in rats with pressure overload hypertrophy due to ascending aortic stenosis.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aortic Valve Stenosis; Blood Pressure; Cardiac Output, Low; Echocardiography; Fosinopril; Hypertension; Hypertrophy, Left Ventricular; In Vitro Techniques; Male; Myocardium; Rats; Rats, Wistar; Survival Analysis; Ventricular Function, Left | 1994 |
Fosinopril in the treatment of hypertension: effects on 24h ambulatory blood pressure and on blood pressure response to exercise.
Topics: Adult; Blood Pressure; Blood Pressure Determination; Exercise; Exercise Test; Female; Fosinopril; Heart Rate; Humans; Hypertension; Male; Middle Aged; Monitoring, Physiologic | 1994 |
Angiotensin-converting enzyme in human skeletal muscle. A simple in vitro assay of activity in needle biopsy specimens.
Topics: Biopsy, Needle; Dipeptides; Female; Fluorometry; Fosinopril; Humans; Hypertension; In Vitro Techniques; Male; Muscles; o-Phthalaldehyde; Peptidyl-Dipeptidase A; Reproducibility of Results | 1994 |
Fosinopril: an overview.
Topics: Fosinopril; Humans; Hypertension | 1993 |
Reduction in left ventricular mass in patients with systemic hypertension treated with enalapril, lisinopril, or fosenopril.
Topics: Adult; Aged; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Enalapril; Female; Fosinopril; Hemodynamics; Humans; Hypertension; Hypertrophy, Left Ventricular; Lisinopril; Male; Middle Aged; Ventricular Function, Left | 1996 |
Chronic ACE-inhibitor treatment and adrenergic mechanisms in spontaneously hypertensive rats.
Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cardiomegaly; Disease Models, Animal; Dose-Response Relationship, Drug; Down-Regulation; Fosinopril; Hypertension; Mesenteric Arteries; Myocardium; Norepinephrine; Radioligand Assay; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Ribonucleases; RNA, Messenger; Synaptic Transmission; Vascular Resistance | 1995 |
Do ACE inhibitors influence the dose of human recombinant erythropoietin in dialysis patients?
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Enalapril; Erythropoietin; Female; Follow-Up Studies; Fosinopril; Hematocrit; Humans; Hypertension; Kidney Failure, Chronic; Male; Recombinant Proteins; Renal Dialysis; Retrospective Studies | 1996 |
Fosinopril reduces ADP-induced platelet aggregation in hypertensive patients.
Topics: Adenosine Diphosphate; Angiotensin-Converting Enzyme Inhibitors; Blood Platelets; Fosinopril; Humans; Hypertension; In Vitro Techniques; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Prodrugs | 1996 |
Long-term angiotensin-converting enzyme inhibition with fosinopril improves depressed responsiveness to Ca2+ in myocytes from aortic-banded rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Calcium; Cardiac Output, Low; Cardiomegaly; Constriction; Fosinopril; Heart; Hypertension; Male; Myocardial Contraction; Myocardium; Rats; Rats, Wistar; Time Factors | 1996 |
[Fosinopril in the cardiovascular management of elderly patients].
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; Diuretics; Drug Therapy, Combination; Female; Fosinopril; Heart Failure; Humans; Hypertension; Hypertension, Renal; Male | 1996 |
Effects of fosinopril on the blood pressure and lipid profile of patients undergoing heart transplantation.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cholesterol; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Fosinopril; Heart Transplantation; Humans; Hypertension; Lipids; Lipoprotein(a); Male; Middle Aged; Postoperative Complications; Treatment Outcome; Triglycerides | 1997 |
Scleroderma and eosinophilic fasciitis in patients taking fosinopril.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Fasciitis; Female; Fosinopril; Humans; Hypertension; Middle Aged; Skin Diseases | 1997 |
Peripheral perfusion and tissue oxygenation improvement induced by antihypertensive medication combined with lipoidoproteinosis treatment.
Topics: Anticholesteremic Agents; Antihypertensive Agents; Drug Therapy, Combination; Exercise Test; Female; Fosinopril; Humans; Hypertension; Lipoid Proteinosis of Urbach and Wiethe; Male; Microcirculation; Middle Aged; Oxygen; Pravastatin | 1997 |
[Therapy of hypertension in the elderly: Fosinopril in Old Patients Study (FOPS)].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Cohort Studies; Female; Fosinopril; Humans; Hypertension; Male; Middle Aged; Treatment Outcome | 1997 |
[Effectiveness and tolerance of fosinopril. ACE inhibitor therapy of hypertensive patients in general practice--clinical observation].
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Female; Fosinopril; Humans; Hypertension; Kidney Function Tests; Male; Middle Aged; Treatment Outcome | 1997 |
Fosinopril national survey: a post-marketing surveillance study of fosinopril (Staril) in general practice in the UK.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Family Practice; Female; Fosinopril; Humans; Hypertension; Male; Middle Aged; Product Surveillance, Postmarketing; United Kingdom | 1997 |
Treatment of hypertensive patients with diabetes.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Case-Control Studies; Cohort Studies; Diabetes Complications; Enalapril; Fosinopril; Humans; Hydrochlorothiazide; Hypertension; Isradipine; Nisoldipine; Randomized Controlled Trials as Topic | 1998 |
Role of angiotensin II in hyperinsulinemia-induced hypertension in rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Chronic Disease; Fosinopril; Hyperinsulinism; Hypertension; Insulin; Kidney; Losartan; Male; Rats; Rats, Sprague-Dawley | 1998 |
Antihypertensive treatment and CHD in the elderly.
Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Diabetes Complications; Double-Blind Method; Felodipine; Fosinopril; Humans; Hypertension; Myocardial Infarction; Nisoldipine; Nitrendipine; Randomized Controlled Trials as Topic | 1999 |
Characterization of MAP kinase and PKC isoform and effect of ACE inhibition in hypertrophy in vivo.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Cardiomegaly; Enzyme Activation; Fosinopril; Hydralazine; Hypertension; Isoenzymes; Mitogen-Activated Protein Kinases; Nuclear Proteins; Phosphoproteins; Protein Kinase C; Rats; Rats, Sprague-Dawley; Response Elements; Transfection | 1999 |
Resistance artery mechanics, structure, and extracellular components in spontaneously hypertensive rats : effects of angiotensin receptor antagonism and converting enzyme inhibition.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Blood Pressure; Body Weight; Collagen; Elastin; Fosinopril; Hypertension; Integrins; Irbesartan; Male; Mesenteric Arteries; Oligopeptides; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrazoles; Vascular Resistance | 1999 |
Transient myocardial dysfunction associated with angiotensin-converting enzyme inhibitor-induced angioedema: recognition by serial echocardiographic studies.
Topics: Angioedema; Angiotensin-Converting Enzyme Inhibitors; Biopsy; Cardiomyopathies; Diagnosis, Differential; Echocardiography; Female; Fosinopril; Humans; Hypertension; Middle Aged; Myocardial Contraction; Stroke Volume | 1999 |
The angiotensin-converting enzyme inhibitor, fosinopril, and the angiotensin II receptor antagonist, losartan, inhibit LDL oxidation and attenuate atherosclerosis independent of lowering blood pressure in apolipoprotein E deficient mice.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Apolipoproteins E; Arteriosclerosis; Drug Administration Schedule; Fosinopril; Hydralazine; Hypertension; Lipid Peroxidation; Lipoproteins, LDL; Losartan; Mice; Mice, Transgenic; Oxidation-Reduction; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2 | 1999 |
Predicting response to chronic antihypertensive treatment with fosinopril: the role of angiotensin-converting enzyme gene polymorphism.
Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Creatinine; Female; Fosinopril; Genotype; Greece; Humans; Hypertension; Male; Middle Aged; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Predictive Value of Tests; Prospective Studies | 2000 |
Drug-related pemphigus and angiotensin converting enzyme inhibitors.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Biopsy, Needle; Fatal Outcome; Female; Fluorescent Antibody Technique; Fosinopril; Humans; Hypertension; Male; Middle Aged; Pemphigus; Prognosis; Risk Assessment | 2000 |
The cardiovascular actions of omapatrilat in spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cardiovascular Agents; Endocardium; Fosinopril; Hemodynamics; Hypertension; Hypertrophy, Left Ventricular; Male; Pyridines; Rats; Rats, Inbred SHR; Thiazepines; Ventricular Function, Left | 2001 |
Effect of angiotensin-converting enzyme inhibitors on glomerular eicosanoid production in normotensive and spontaneously hypertensive rats.
Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Culture Techniques; Dinoprostone; Eicosanoids; Enalapril; Fosinopril; Hypertension; Kidney Glomerulus; Male; Proline; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Thromboxane A2 | 1991 |
Blood pressure lowering and renal hemodynamic effects of fosinopril in conscious animal models.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Desoxycorticosterone; Dogs; Female; Fosinopril; Hemodynamics; Hydrochlorothiazide; Hypertension; Hypertension, Renal; Macaca fascicularis; Male; Potassium; Proline; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Renal Circulation; Sodium | 1990 |
Antihypertensive activity during inhibition of neutral endopeptidase and angiotensin converting enzyme.
Topics: Amino Acids; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Captopril; Fosinopril; Hypertension; Male; Neprilysin; Organophosphorus Compounds; Proline; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Sulfhydryl Compounds | 1991 |
Immediate and short-term cardiovascular effects of fosinopril, a new angiotensin-converting enzyme inhibitor, in patients with essential hypertension.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Echocardiography; Female; Fosinopril; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Norepinephrine; Proline; Renal Circulation; Renin; Vascular Resistance | 1991 |
Hemodynamic alterations associated with progression of renal allograft injury.
Topics: Angiotensin-Converting Enzyme Inhibitors; Fosinopril; Glomerular Filtration Rate; Hemodynamics; Humans; Hypertension; Kidney Transplantation; Postoperative Complications; Proline; Reference Values; Renal Circulation; Transplantation, Homologous | 1991 |
Three new ACE inhibitors for hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Bridged Bicyclo Compounds; Drug Interactions; Fosinopril; Heart Failure; Humans; Hypertension; Prodrugs; Proline; Ramipril | 1991 |
Fosinopril (Staril)--another ACE inhibitor.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Fosinopril; Humans; Hypertension; Proline | 1991 |
The effect of fosinopril sodium on cerebral blood flow in moderate essential hypertension.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Cerebrovascular Circulation; Chlorthalidone; Female; Fosinopril; Humans; Hypertension; Lower Body Negative Pressure; Male; Middle Aged; Organophosphorus Compounds; Proline; Rest; Tomography, Emission-Computed, Single-Photon | 1990 |
Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE).
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Bridged Bicyclo Compounds; Captopril; Chemotherapy, Cancer, Regional Perfusion; Dose-Response Relationship, Drug; Enalapril; Fosinopril; Heart; Hypertension; Lisinopril; Male; Organophosphorus Compounds; Proline; Ramipril; Rats; Time Factors; Tissue Distribution | 1989 |